Stock Rich List
Nasdaq: AMLX

Amylyx Pharmaceuticals insiders

The officers, directors and 10% owners of Amylyx Pharmaceuticals, Inc. who hold the most stock, valued at the live AMLX price.

$26.20
AMLX today −$420K (−1.58%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
10
Their AMLX stock
$580M
Market value
$3.37B
Held by ranked insiders
17.2%

Insiders by value of AMLX holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1ALS Invest 1 B.V.10% owner5,895,280$154M4.59%Corporate
2Morningside Venture Investments Ltd10% owner4,997,302$131M3.89%Corporate
3Joshua B. CohenCo-Chief Executive Officer3,513,123$92.0M2.73%1598th
4Justin B. KleeCo-Chief Executive Officer3,513,056$92.0M2.73%1599th
5Dragsa 96 LLC10% owner2,300,000$60.3M1.79%Corporate
6George M. Milne Jr.Director782,881$20.5M0.61%4876th
7James M. FratesChief Financial Officer384,697$10.1M0.30%8734th
8Camille L. BedrosianChief Medical Officer278,064$7.3M0.22%9589th
9Margaret OlingerChief Commercial Officer276,108$7.2M0.21%11150th
10Patrick D. YeramianChief Medical Officer205,605$5.4M0.16%13745th

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Amylyx Pharmaceuticals; see each profile for the filing.